E.C. Klasen

1.4k total citations
39 papers, 1.2k citations indexed

About

E.C. Klasen is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, E.C. Klasen has authored 39 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 15 papers in Cancer Research and 7 papers in Genetics. Recurrent topics in E.C. Klasen's work include Protease and Inhibitor Mechanisms (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Lipoproteins and Cardiovascular Health (5 papers). E.C. Klasen is often cited by papers focused on Protease and Inhibitor Mechanisms (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Lipoproteins and Cardiovascular Health (5 papers). E.C. Klasen collaborates with scholars based in Netherlands, United Kingdom and United States. E.C. Klasen's co-authors include Louis M. Havekes, M. Smit, Peter de Knijff, Ulrike Beisiegel†, L.N. Went, Rune R. Frants, Johannes A. Kramps, Maryvonne Rosseneu, J Bury and Marcel Nelen and has published in prestigious journals such as Science, Analytical Biochemistry and Gut.

In The Last Decade

E.C. Klasen

39 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E.C. Klasen Netherlands 18 448 339 324 319 168 39 1.2k
Mauricio P. Pinto Chile 20 462 1.0× 322 0.9× 298 0.9× 391 1.2× 438 2.6× 56 1.4k
Brian Sheppard Ireland 25 560 1.3× 104 0.3× 440 1.4× 95 0.3× 102 0.6× 79 2.6k
Treena Cranston United Kingdom 22 477 1.1× 361 1.1× 146 0.5× 209 0.7× 442 2.6× 45 1.8k
Linda S. Wood United States 20 392 0.9× 324 1.0× 152 0.5× 118 0.4× 283 1.7× 45 1.2k
Ahmed Zaid Sweden 13 582 1.3× 575 1.7× 223 0.7× 114 0.4× 166 1.0× 24 1.4k
Anne M. Deschamps United States 18 570 1.3× 269 0.8× 330 1.0× 218 0.7× 276 1.6× 27 1.7k
John Mandeli United States 24 608 1.4× 262 0.8× 323 1.0× 73 0.2× 659 3.9× 82 2.2k
Jamal Zidan Israel 23 309 0.7× 268 0.8× 205 0.6× 252 0.8× 518 3.1× 80 1.5k
Yang‐Min Ning United States 17 594 1.3× 161 0.5× 223 0.7× 193 0.6× 566 3.4× 33 1.7k
George Thomas United States 9 903 2.0× 230 0.7× 79 0.2× 94 0.3× 183 1.1× 23 1.4k

Countries citing papers authored by E.C. Klasen

Since Specialization
Citations

This map shows the geographic impact of E.C. Klasen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.C. Klasen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.C. Klasen more than expected).

Fields of papers citing papers by E.C. Klasen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.C. Klasen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.C. Klasen. The network helps show where E.C. Klasen may publish in the future.

Co-authorship network of co-authors of E.C. Klasen

This figure shows the co-authorship network connecting the top 25 collaborators of E.C. Klasen. A scholar is included among the top collaborators of E.C. Klasen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.C. Klasen. E.C. Klasen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meijer, Ingeborg, et al.. (2010). Societal output and use of research performed by health research groups. Health Research Policy and Systems. 8(1). 30–30. 32 indexed citations
2.
Klasen, E.C., et al.. (2007). Maatschappelijke impact van gezondheidsonderzoek. TSG - Tijdschrift voor gezondheidswetenschappen. 85(5). 259–261. 5 indexed citations
3.
Blom, C.W.P.M., E.C. Klasen, & J. Van Steveninck. (1990). Different characteristics of ferrochelatase in cultured fibroblasts of erythropoietic protoporphyria patients and normal controls. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1039(3). 339–342. 3 indexed citations
4.
Haeringen, Arie van, Wilma Bergman, Marcel Nelen, et al.. (1989). Exclusion of the dysplastic nevus syndrome (DNS) locus from the short arm of chromosome 1 by linkage studies in dutch families. Genomics. 5(1). 61–64. 60 indexed citations
5.
Hofker, Marten H., Toshihiro Nukiwa, Marcel Nelen, et al.. (1989). A Pro → Leu substitution in codon 369 of the alpha-1-antitrypsin deficiency variant PI MHeerlen. Human Genetics. 81(3). 264–268. 35 indexed citations
6.
Smit, M., et al.. (1988). Apolipoprotein gene cluster on chromosome 19. Human Genetics. 78(1). 90–93. 58 indexed citations
7.
Biemond, Izäk, et al.. (1988). The Flaccid Lung Syndrome and α1-Protease Inhibitor Deficiency. CHEST Journal. 93(4). 831–835. 4 indexed citations
8.
Smit, M., Peter de Knijff, Alice J.A.M. Sijts, et al.. (1988). Rare Apolipoprotein E Variant Cosegregating with a Unique APOE-C1-C2 Haplotype in a Normolipidemic Family. Human Heredity. 38(5). 277–282. 8 indexed citations
9.
Biemond, I., et al.. (1988). Alpha-1-Antitrypsin Phenotypes and Serum Concentrations in Duodenal Ulcer Patients in The Netherlands. Digestion. 39(1). 20–25. 1 indexed citations
10.
Smit, M., Peter de Knijff, Maryvonne Rosseneu, et al.. (1988). Apolipoprotein E polymorphism in the Netherlands and its effect on plasma lipid and apolipoprotein levels. Human Genetics. 80(3). 287–292. 113 indexed citations
11.
Padberg, George W., et al.. (1988). Linkage studies in facioscapulo‐humeral muscular dystrophy. Muscle & Nerve. 11(8). 833–835. 13 indexed citations
12.
Kramps, J. A., et al.. (1988). Interactions among stimulated human polymorphonuclear leucocytes, released elastase and bronchial antileucoprotease. Clinical Science. 75(1). 53–62. 47 indexed citations
13.
Klasen, E.C., et al.. (1987). Detection of alpha-1-antitrypsin deficiency variants by synthetic oligonucleotide hybridization. Clinica Chimica Acta. 170(2-3). 201–207. 9 indexed citations
14.
Frants, Rune R., et al.. (1987). Familial dysbetalipoproteinemic subjects with the E3/E2 phenotype exhibit an E2 isoform with only one cysteine residue. Clinical Genetics. 32(5). 335–341. 9 indexed citations
15.
Klasen, E.C., et al.. (1987). Apolipoprotein E Phenotype and Gene Distribution in The Netherlands. Human Heredity. 37(6). 340–344. 26 indexed citations
16.
Doeglas, H. M. G., E.C. Klasen, & E. Bleumink. (1985). α1-antitrypsin deficiency and PI typing in patients with chronic urticaria. British Journal of Dermatology. 112(4). 381–385. 13 indexed citations
17.
Klasen, E.C.. (1981). α<sub>1</sub>-Antitrypsin Phenotype and Gene Distribution in Southern Italy. Human Heredity. 31(3). 180–182. 13 indexed citations
18.
Klasen, E.C., et al.. (1980). alpha 1-Antitrypsin and coeliac disease in spain.. Gut. 21(11). 948–950. 14 indexed citations
19.
Klasen, E.C., I. Biemond, & Irene T. Weterman. (1980). alpha 1-Antitrypsin-levels and phenotypes in Crohn's disease in the Netherlands.. Gut. 21(10). 840–842. 9 indexed citations
20.
Klasen, E.C., et al.. (1978). Phenotype and Gene Distribution of Alpha-1-Antitrypsin in a North Italian Population. Human Heredity. 28(6). 474–478. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026